Natural Alternatives International (NAII) 10-Q 13 Feb 18 2018 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Dec. 31, 2017	Feb. 13, 2018
Document Information [Line Items]
Entity Registrant Name	NATURAL ALTERNATIVES INTERNATIONAL INC
Entity Central Index Key	787,253
Trading Symbol	naii
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		7,429,020
Document Type	10-Q
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Dec. 31, 2017	Jun. 30, 2017
Assets
Cash and cash equivalents	$ 28,843,000	$ 27,843,000
Accounts receivable - less allowance for doubtful accounts of $14 at December 31, 2017 and $18 at June 30, 2017	12,895,000	8,410,000
Notes receivable	1,500,000
Inventories, net	17,879,000	13,729,000
Income tax receivable		261,000
Prepaids and other current assets	1,585,000	1,456,000
Total current assets	62,702,000	51,699,000
Property and equipment, net	18,733,000	18,136,000
Deferred income taxes	2,443,000	2,002,000
Other noncurrent assets, net	709,000	774,000
Total assets	84,587,000	72,611,000
Liabilities and Stockholders’ Equity
Accounts payable	12,182,000	5,116,000
Accrued liabilities	2,215,000	1,931,000
Accrued compensation and employee benefits	1,089,000	1,594,000
Forward contract	2,088,000	422,000
Income taxes payable	1,636,000	1,207,000
Total current liabilities	19,210,000	10,270,000
Long-term pension liability	409,000	557,000
Deferred rent	551,000	537,000
Forward contract, noncurrent	609,000	99,000
Income taxes payable, noncurrent	2,950,000
Total liabilities	23,729,000	11,463,000
Commitments and contingencies
Stockholders’ equity:
Preferred stock; $.01 par value; 500,000 shares authorized; none issued or outstanding	0	0
Common stock; $.01 par value; 20,000,000 shares authorized; issued and outstanding (net of treasury shares) 7,429,020 at December 31, 2017 and 6,937,018 at June 30, 2017	84,000	79,000
Additional paid-in capital	23,266,000	22,260,000
Retained earnings	45,904,000	45,788,000
Treasury stock, at cost, 1,052,657 shares at December 31, 2017 and 1,044,659 June 30, 2017	(6,160,000)	(6,074,000)
Accumulated other comprehensive loss	(2,236,000)	(905,000)
Total stockholders’ equity	60,858,000	61,148,000
Total liabilities and stockholders’ equity	$ 84,587,000	$ 72,611,000

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2017	Jun. 30, 2017
Accounts receivable, allowance for doubtful accounts	$ 14	$ 18
Preferred stock par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, issued (in shares)	7,429,020	6,937,018
Common stock, outstanding (in shares)	7,429,020	6,937,018
Treasury stock, shares (in shares)	1,052,657	1,044,659

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Net sales	$ 33,335	$ 30,559	$ 61,409	$ 64,626
Cost of goods sold	26,713	24,064	48,417	50,462
Gross profit	6,622	6,495	12,992	14,164
Selling, general and administrative	4,341	3,382	8,828	7,515
Income from operations	2,281	3,113	4,164	6,649
Other income (expense):
Interest income	304	133	554	249
Foreign exchange (loss) gain	(88)	262	(231)	203
Other, net	(14)	(8)	(13)	(15)
Total other income	202	387	310	437
Income before income taxes	2,483	3,500	4,474	7,086
Provision for income taxes	3,801	1,034	4,358	2,130
Net (loss) income	(1,318)	2,466	116	4,956
Unrealized (loss) gain resulting from change in fair value of derivative instruments, net of tax	(197)	1,242	(1,331)	852
Comprehensive (loss) income	$ (1,515)	$ 3,708	$ (1,215)	$ 5,808
Net (loss) income per common share:
Basic (in dollars per share)	$ (0.20)	$ 0.38	$ 0.02	$ 0.76
Diluted (in dollars per share)	$ (0.20)	$ 0.37	$ 0.02	$ 0.74
Weighted average common shares outstanding
Basic (in shares)	6,615,355	6,567,468	6,610,937	6,562,932
Diluted (in shares)	6,615,355	6,683,356	6,836,567	6,665,159

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities
Net (loss) income	$ 116	$ 4,956
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,479	1,059
Deferred income taxes	306
Non-cash sales discount	408
Non-cash compensation	603	506
Pension expense, net of contributions	(148)	100
Gain on disposal of assets	(2)	(23)
Changes in operating assets and liabilities:
Accounts receivable, net	(4,485)	3,379
Inventories, net	(4,150)	3,701
Prepaids and other assets	(64)	42
Accounts payable and accrued liabilities	6,942	(6,721)
Accrued compensation and employee benefits	(505)	(1,726)
Forward contracts	520	(491)
Income taxes	3,640	255
Net cash provided by operating activities	4,660	5,037
Cash flows from investing activities
Purchases of property and equipment	(2,095)	(3,362)
Proceeds from sale of property and equipment	21	24
Issuance of notes receivable	(1,500)
Net cash used in investing activities	(3,574)	(3,338)
Cash flows from financing activities
Repurchase of common stock	(86)	(84)
Net cash used in financing activities	(86)	(84)
Net increase in cash and cash equivalents	1,000	1,615
Cash and cash equivalents at beginning of period	27,843	19,747
Cash and cash equivalents at end of period	28,843	21,362
Supplemental disclosures of cash flow information
Interest
Taxes	422	1,897
Disclosure of non-cash activities:
Change in unrealized (loss) gain resulting from change in fair value of derivative instruments, net of tax	$ (1,331)	$ 852

Note A - Basis of Presentation

Note A - Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	A. Basis of Presentation and Summary of Significant Accounting Policies The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10 ’s opinion, all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows have been included and are of a normal, recurring nature. The results of operations for the three six December 31, 2017 not You should read the financial statements and these notes, which are an integral part of the financial statements, together with our audited financial statements included in our Annual Report on Form 10 June 30, 201 7 “2017 2017 Recent Accounting Pronouncements In March 2016, No. 2016 02, 842 2016 02 existing standards for leases to increase transparency and comparability among organizations by requiring recognition of lease assets and liabilities on the balance sheet and requiring disclosure of key information about such arrangements. ASU 2016 02 first 2020. In April 2016, No. 2016 10, 606 2016 10 2014 0 9 May 2016, No. 2016 11, 605 815 2016 11 2014 09. May 2016 No. 2016 12, 606 2016 12 2014 09. 2014 09 five may may All of these new standards will be effective for us concurrently with ASU 2014 09, first 2019. not 606. In August 2017, 2017 12, 815 Activities. The ASU is intended to improve and simplify accounting rules around hedge accounting and improve the disclosures of hedging arrangements. We are currently evaluating the impact of adopting the new standard on our consolidated financial statements. ASU 2017 12 first 2020. On December 22, 2017, No. 118, 118” not In accordance with SAB 118, . Net Income per Common Share We compute net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options account for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, 201 7 2016 201 7 2016 Numerator Net (loss) i ncome $ (1,318 ) $ 2,466 $ 116 $ 4,956 Denominator Basic weighted average common shares outstanding 6,615 6,567 6,611 6,563 Dilutive effect of stock options — 116 226 102 Diluted weighted average common shares outstanding 6,615 6,683 6,837 6,665 Basic net (loss) income per common share $ (0.20 ) $ 0.38 $ 0.02 $ 0.76 Diluted net (loss) income per common share $ (0.20 ) $ 0.37 $ 0.02 $ 0.74 In periods where we have a net loss, stock options and restricted stock are excluded from our calculation of diluted net income (loss) per common share, as their inclusion would have an antdilutive effect. We excluded shares related to stock options totaling 1 35,000 813,665 three December 31, 2017. No six December 31, 2017 three six December 31, 2016. Revenue Recognition To recognize revenue, four 1 with a buyer exists; 2 3 4 not not not We record reductions to gross revenue for estimated returns of private-label contract manufacturing products and beta-alanine raw material sales. The estimated returns are based on the trailing six sales returns. However, the estimate for product returns does not not On August 7, 2017, three Agreements”), with The Juice Plus+ Company LLC (“Juice Plus+”). The Agreements are an Exclusive Manufacturing Agreement, a Restricted Stock Award Agreement, and an Irrevocable Proxy. Pursuant to the Exclusive Manufacturing Agreement, Juice Plus+ has granted us exclusive rights to manufacture and supply them with certain of their products within 24 500,000 5 may We recorded of $245,000 three December 31, 2017 $408,000 six December 31, 2017. We currently own certain U.S. patents and patent applications, and corresponding foreign patents and patent applications. All of these patents and patent rights relate to the ingredient known as beta-alanine and which we market and sell under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $4.0 three December 31, 2017 $9.8 six December 31, 2017. $6.7 three December 31, 2016 $13.4 six December 31, 2016. $160,000 three December 31, 2017 $444,000 six December 31, 2017. $250,000 three December 31, 2016 $566,000 six December 31, 2016. Notes Receivab le On September 30, 2017, 12 one $1.5 one fifteen 15% three six December 31, 2017 $58,000 Stock-Based Compensation We have an omnibus incentive plan that was approved by our Board of Directors effective as of October 15, 2009 November 30, 2009. may We estimate the fair value of stock option awards at the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no to date we have not We did not three x December 31, 2017 2016. No three six December 31, 2017 2016. no three December 31, 2017. six December 31, 2017 5,000 no three six December 31, 2016. We did not three six December 31, 2017 , or the three December 31, 2016. 10,000 six December 31, 2016. $302,000 three December 31, 2017, $603,000 six December 31, 2017. $256,000 three December 31, 2016, $506,000 six December 31, 2016. Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We use a three sources. Unobservable inputs are inputs that reflect our assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available under the circumstances. The fair value hierarchy is broken down into three 1 1 2 not 3 As of Dec ember 31, 2017 June 30, 2017, not 1 2 December 31, 2017 $2.7 June 30, 2017 $521,000. December 31, 2017 June 30, 2017 not 3. not 2017 six December 31, 2017. Concentrations of Credit Risk Financial instruments that subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with highly rated financial institutions. Credit risk with respect to rec eivables is concentrated with our three 76.1% December 31, 2017 65.6% June 30, 2017. 15.6% December 31, 2017, 21.3% June 30, 2017.

Note B - Inventories, Net

Note B - Inventories, Net	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Inventory Disclosure [Text Block]	B. Inventories, net Inventories, net consisted of the following (in thousands): December 31, 201 7 June 30, 201 7 Raw materials $ 12,623 $ 9,469 Work in progress 3,061 1,312 Finished goods 2,597 3,562 Reserves (402 ) (614 ) Inventories, net $ 17,879 $ 13,729

Note C - Property and Equipment

Note C - Property and Equipment	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	C. Property and Equipment Property and equipment consisted of the following (in thousands): Depreciable Life In Years December 31 , 2017 June 30, 201 7 Land N/A $ 1,200 $ 1,200 Building and building improvements 7 – 39 3,715 3,706 Machinery and equipment 3 – 12 25,499 24,194 Office equipment and furniture 3 – 5 4,350 3,954 Vehicles 3 209 209 Leasehold improvements 1 – 15 17,032 17,038 Total property and equipment 52,005 50,301 Less: accumulated depreciation and amortization (33,272 ) (32,165 ) Property and equipment, net $ 18,733 $ 18,136

Note D - Other Comprehensive (L

Note D - Other Comprehensive (Loss) Income	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Comprehensive Income (Loss) Note [Text Block]	D. Other Comprehensive (Loss) Income O ther comprehensive (loss) income (“OCL” and “OCI”) consisted of the following during the three six December 31, 2017 December 31, 2016 ( Three Months Ended Six Months Ended December 31, 201 7 December 31, 201 7 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Be ginning Balance $ (491 ) $ (1,548 ) $ (2,039 ) $ (491 ) $ (414 ) $ (905 ) OCI/OCL before reclassifications - (490 ) (490 ) - (2,443 ) (2,443 ) Amounts reclassified from OCI - 187 187 - 365 365 Tax effect of OCI activity - 106 106 - 747 747 Net current period OCI/OCL - (197 ) (197 ) - (1,331 ) (1,331 ) Ending Balance $ (491 ) $ (1,745 ) $ (2,236 ) $ (491 ) $ (1,745 ) $ (2,236 ) Three Months Ended Six Months Ended December 31, 2016 December 31, 2016 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (775 ) $ (295 ) $ (1,070 ) $ (775 ) $ 95 $ (680 ) OCI/OCL before reclassifications - 2,287 2,287 - 1,834 1,834 Amounts reclassified from OCI - (343 ) (343 ) - (501 ) (501 ) Tax effect of OCI activity - (702 ) (702 ) - (481 ) (481 ) Net current period OCI/OCL - 1,242 1,242 - 852 852 Ending Balance $ (775 ) $ 947 $ 172 $ (775 ) $ 947 $ 172

Note E - Debt

Note E - Debt	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	E. Debt We have a Credit Agreement with Wells Fargo Bank, N.A. The Credit Agreement provides us with a credit line of up to $10.0 February 1, 2020. may September 29, 2017, third not $1.5 $1.5 no no Under the terms of the Credit Agreement, borrowings are subject to eligibility requirements including maintaining (i) a ratio of total liabilities to tangible net worth of not 1.25 1.0 not 1.75 1.0 $100,000 1.25% one 1.25% first the maturity date. Amounts outstanding that are subject to a fluctuating interest rate may may $100,000, Our obligations under the Credit Agreement are secured by our accounts receivable and other rights to payment, general intangibles, inventory, equipment and fixtures. On December 31, 2017 , we were in compliance with all of the financial and other covenants required under the Credit Agreement. We also have a foreign exchange facility with Wells Fargo Bank, N.A. in effect until January 31, 2019, August 15, 2019. We did not x December 31, 2017. December 31, 2017, $10.0

Note F - Economic Dependency

Note F - Economic Dependency	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	F. Economic Dependency We had substantial net sales to certain customers during the periods shown in the following table. The loss of any of these customers, or a significant decline in sales to these customers, the growth rate of sales to these customers, or in these customers ’ ability to make payments when due, could have a material adverse impact on our net sales and net income. Net sales to any one 10% Three Months Ended December 31, Six Months Ended December 31, 201 7 2016 201 7 2016 Customer 1 $ 19,134 $ 15,074 $ 32,292 $ 32,152 Customer 2 4,079 (a) 7,239 (a) $ 23,213 $ 15,074 $ 39,531 $ 32,152 (a) Sales were less than 10% We buy certain products, including beta-alanine, from a limited number of raw material suppliers. The loss of any of these suppliers could have a material adverse impact on our net sales and net income. Raw material purchases from any one 10% ’s total raw material purchases were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 201 7 2016 201 7 2016 Supplier 1 $ (a) (a) $ 2,992 (a) Supplier 2 1,684 (a) 2,911 (a) Supplier 3 1,718 (a) (a) (a) $ 3,402 — $ 5,903 — (a) Purchases were less than 10% ’s total raw material purchases.

Note G - Segment Information

Note G - Segment Information	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	G. Segment Information Our business consists of two and SR CarnoSyn® trade names. We evaluate performance based on a number of factors. The primary performance measures for each segment are net sales and income or loss from operations before corporate allocations. Operating income or loss for each segment does not , which are not not 2017 Our operating results by business segment were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2017 2016 2017 2016 Net Sales Private label contract manufacturing $ 29,355 $ 23,864 $ 51,577 $ 51,243 Patent and trademark licensing 3,980 6,695 9,832 13,383 Total Net Sales $ 33,335 $ 30,559 $ 61,409 $ 64,626 Three Months Ended December 31, Six Months Ended December 31, 2017 2016 2017 2016 Income from Operations Private label contract manufacturing $ 3,385 $ 2,148 $ 5,641 $ 5,462 Patent and trademark licensing 504 2,340 1,692 4,240 Income from operations of reportable segments 3,889 4,488 7,333 9,702 Corporate expenses not allocated to segments (1,608 ) (1,375 ) (3,169 ) (3,053 ) Total Income from Operations $ 2,281 $ 3,113 $ 4,164 $ 6,649 Total Assets December 31, 201 7 June 30, 201 7 Private label contract manufacturing $ 72,115 $ 60,489 Patent and Trademark Licensing 12,472 12,122 Total $ 84,587 $ 72,611 Our private label contract manufacturing products are sold both in the U.S. and in markets outside the U. S., including Europe, Australia and Asia, as well as Canada, Mexico and South Africa. Our primary market outside the U.S. is Europe. Our patent and trademark licensing activities are primarily based in the U.S. Net sales by geographic region, based on the customers ’ location, were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2017 2016 2017 2016 United States $ 16,426 $ 13,654 $ 31,620 $ 28,879 Markets outside of the United States 16,909 16,905 29,789 35,747 Total $ 33,335 $ 30,559 $ 61,409 $ 64,626 Products manufactured by NAIE accounted for 81% three December 31, 2017, 79% six December 31, 2017. 60% three December 31, 2016, 53% six December 31, 2016. No three six December 31, 2017 2016. Assets and capital expenditures by geographic region, based on the location of the company or subsidiary at which they were located or made, were as follows (in thousands): Long-Lived Assets Total Assets Capital Expenditures Six Months Ended December 31, 201 7 June 30, 201 7 December 31, 201 7 June 30, 201 7 December 31, 201 7 December 31, 201 6 United States $ 10,461 $ 10,753 $ 53,353 $ 47,777 $ 426 $ 1,812 Europe 8,272 7,383 31,234 24,834 1,669 1,550 $ 18,733 $ 18,136 $ 84,587 $ 72,611 $ 2,095 $ 3,362

Note H - Income Taxes

Note H - Income Taxes	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Income Tax Disclosure [Text Block]	H. Income Taxes The Tax Cuts and Jobs Act (the “Act”) was enacted on December 22, 2017. Among other things, the Act reduces the U.S. federal corporate tax rate to 21% one December 31, 2017, not 1 18, one not 740, may one December 22, 2018 due to, among other things, further refinement of our calculations, changes in interpretations and assumptions we made, guidance that may may To determine our quarterly provision for income taxes, we use an estimated annual effective tax rate that is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions to which we are subject. Certain significant or unusual items are separately recognized as discrete items in the quarter in which they occur and can be a source of variability in the effective tax rate from quarter to quarter. We recognize interest and penalties related to uncertain tax positions, if any, as an income tax expense. The effective tax rate for the three December 31, 2017 153.1% six December 31, 2017 97.31%. three December 31, 2016 29.6 six December 31, 2016 30.1%. three six December 31, 2017 28.06% one June 30, 2018 28.06% 35% 21% 21% June 30, 2018. As part of the Act, we are required to recognize a one 1986 one three six December 31, 2017 $1,815,966 eight may 2018. December 31, 2017, no $775,000 Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates for each of the jurisdictions in which we operate, expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. As of December 31, 2017, 2018 28.06% 21% $664,000 three six December 31, 2017. We record valuation allowances to reduce our deferred tax assets to an amount that we believe is more likely than not not three six December 31, 2017, no We are subject to taxation in the U.S., Switzerland and various U.S. state jurisdictions. Our tax returns for the fiscal years ended June 30, 2014 June 30, 2007 June 30, 2015 It is our policy to establish reserves based on management ’s assessment of exposure for certain positions taken in previously filed tax returns that may no three six December 31, 2017.

Note I - Treasury Stock

Note I - Treasury Stock	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Treasury Stock [Text Block]	I. Treasury Stock On June 2, 2011, $2.0 February 6, 2015, $1.0 $3.0 May 11, 2015, $2.0 $5.0 March 28, 2017, $2.0 $7.0 may, may During the three six December 31, 2017 December 31, 2016, not During the three December 31, 2017, 7,264 $10.80 $78,000. six December 31, 2017, 7,998 $10.79 $86,000. three December 31, 2016, 367 $12.30 $5,000. six December 31, 2016, 6,404 $13.09 $84,000. These shares were returned to NAI by the related employees and in return NAI paid each employee’s required tax withholding required as a result of the vesting of the restricted shares. The valuation of the shares acquired and thereby the number of shares returned to NAI was calculated based on the closing share price on the date the restricted shares vested.

Note J - Derivatives and Hedgin

Note J - Derivatives and Hedging	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Derivative Instruments and Hedging Activities Disclosure [Text Block]	J. Derivatives and Hedging We are exposed to gains and losses resulting from fluctuations in foreign currency exchange rates relating to forecasted product sales and transactions of NAIE, our foreign subsidiary denominated in foreign currencies. As part of our overall strategy to manage the level of exposure to the risk of fluctuations in foreign currency exchange rates, we sometimes no As of December 31, 201 7, August 2019. For foreign currency contracts designated as cash flow hedges, hedge effectiveness is measured using the spot rate. Changes in the spot-forward differential are excluded from the test of hedge effectiveness and are recorded currently in earnings as interest expense or income. We measure effectiveness by comparing the cumulative change in the hedge contract with the cumulative change in the hedged item. We did not three six December 31, 2017. three six December 31, 2016, $92,000 None no As of December 31, 201 7, $52.6 45.3 December 31, 2017, $2.7 $2.0 12 As of December 31, 2017 , the fair value of our cash flow hedges was a liability of $2.7 $2.1 $609,000 three December 31, 2017, $731,000 $428,000 six December 31, 2017, $2.9 $850,000 June 30, 2017, $422,000 $99,000 three December 31, 2016, $2.3 $213,000 six December 31, 2016, $1.8 $271,000

Note K - Contingencies

Note K - Contingencies	6 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Legal Matters and Contingencies [Text Block]	K. Contingencies From time to time, we become involved in various investigations, claims and legal proceedings that arise in the ordinary course of our business. These matters may not not

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In March 2016, No. 2016 02, 842 2016 02 existing standards for leases to increase transparency and comparability among organizations by requiring recognition of lease assets and liabilities on the balance sheet and requiring disclosure of key information about such arrangements. ASU 2016 02 first 2020. In April 2016, No. 2016 10, 606 2016 10 2014 0 9 May 2016, No. 2016 11, 605 815 2016 11 2014 09. May 2016 No. 2016 12, 606 2016 12 2014 09. 2014 09 five may may All of these new standards will be effective for us concurrently with ASU 2014 09, first 2019. not not 606. In August 2017, 2017 12, 815 Activities. The ASU is intended to improve and simplify accounting rules around hedge accounting and improve the disclosures of hedging arrangements. We are currently evaluating the impact of adopting the new standard on our consolidated financial statements. ASU 2017 12 first 2020. On December 22, 2017, No. 118, 118” not In accordance with SAB 118, $3.3 118, $3.3 .
Earnings Per Share, Policy [Policy Text Block]	Net Income per Common Share We compute net income per common share using the weighted average number of common shares outstanding during the period, and diluted net income per common share using the additional dilutive effect of all dilutive securities. The dilutive impact of stock options account for the additional weighted average shares of common stock outstanding for our diluted net income per common share computation. We calculated basic and diluted net income per common share as follows (in thousands, except per share data): Three Months Ended Six Months Ended December 31, December 31, 201 7 2016 201 7 2016 Numerator Net (loss) i ncome $ (1,318 ) $ 2,466 $ 116 $ 4,956 Denominator Basic weighted average common shares outstanding 6,615 6,567 6,611 6,563 Dilutive effect of stock options — 116 226 102 Diluted weighted average common shares outstanding 6,615 6,683 6,837 6,665 Basic net (loss) income per common share $ (0.20 ) $ 0.38 $ 0.02 $ 0.76 Diluted net (loss) income per common share $ (0.20 ) $ 0.37 $ 0.02 $ 0.74 In periods where we have a net loss, stock options and restricted stock are excluded from our calculation of diluted net income (loss) per common share, as their inclusion would have an antdilutive effect. We excluded shares related to stock options totaling 1 35,000 813,665 three December 31, 2017. No six December 31, 2017 three six December 31, 2016.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition To recognize revenue, four 1 with a buyer exists; 2 3 4 not not not We record reductions to gross revenue for estimated returns of private-label contract manufacturing products and beta-alanine raw material sales. The estimated returns are based on the trailing six sales returns. However, the estimate for product returns does not not On August 7, 2017, three Agreements”), with The Juice Plus+ Company LLC (“Juice Plus+”). The Agreements are an Exclusive Manufacturing Agreement, a Restricted Stock Award Agreement, and an Irrevocable Proxy. Pursuant to the Exclusive Manufacturing Agreement, Juice Plus+ has granted us exclusive rights to manufacture and supply them with certain of their products within 24 500,000 5 may We recorded of $245,000 three December 31, 2017 $408,000 six December 31, 2017. We currently own certain U.S. patents and patent applications, and corresponding foreign patents and patent applications. All of these patents and patent rights relate to the ingredient known as beta-alanine and which we market and sell under our CarnoSyn® and SR CarnoSyn® trade names. We recorded beta-alanine raw material sales and royalty and licensing income as a component of revenue in the amount of $4.0 three December 31, 2017 $9.8 six December 31, 2017. $6.7 three December 31, 2016 $13.4 six December 31, 2016. $160,000 three December 31, 2017 $444,000 six December 31, 2017. $250,000 three December 31, 2016 $566,000 six December 31, 2016.
Finance, Loans and Leases Receivable, Policy [Policy Text Block]	Notes Receivab le On September 30, 2017, 12 one $1.5 one fifteen 15% three six December 31, 2017 $58,000
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation We have an omnibus incentive plan that was approved by our Board of Directors effective as of October 15, 2009 November 30, 2009. may We estimate the fair value of stock option awards at the date of grant using the Black-Scholes option valuation model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no to date we have not We did not three x December 31, 2017 2016. No three six December 31, 2017 2016. no three December 31, 2017. six December 31, 2017 5,000 no three six December 31, 2016. We did not three six December 31, 2017 , or the three December 31, 2016. 10,000 six December 31, 2016. $302,000 three December 31, 2017, $603,000 six December 31, 2017. $256,000 three December 31, 2016, $506,000 six December 31, 2016.
Fair Value Measurement, Policy [Policy Text Block]	Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. We use a three sources. Unobservable inputs are inputs that reflect our assumptions about the inputs that market participants would use in pricing the asset or liability and are developed based on the best information available under the circumstances. The fair value hierarchy is broken down into three 1 1 2 not 3 As of Dec ember 31, 2017 June 30, 2017, not 1 2 December 31, 2017 $2.7 June 30, 2017 $521,000. December 31, 2017 June 30, 2017 not 3. not 2017 six December 31, 2017.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk Financial instruments that subject us to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with highly rated financial institutions. Credit risk with respect to rec eivables is concentrated with our three 76.1% December 31, 2017 65.6% June 30, 2017. 15.6% December 31, 2017, 21.3% June 30, 2017.

Note A - Basis of Presentatio18

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Six Months Ended December 31, December 31, 201 7 2016 201 7 2016 Numerator Net (loss) i ncome $ (1,318 ) $ 2,466 $ 116 $ 4,956 Denominator Basic weighted average common shares outstanding 6,615 6,567 6,611 6,563 Dilutive effect of stock options — 116 226 102 Diluted weighted average common shares outstanding 6,615 6,683 6,837 6,665 Basic net (loss) income per common share $ (0.20 ) $ 0.38 $ 0.02 $ 0.76 Diluted net (loss) income per common share $ (0.20 ) $ 0.37 $ 0.02 $ 0.74

Note B - Inventories, Net (Tabl

Note B - Inventories, Net (Tables)	6 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31, 201 7 June 30, 201 7 Raw materials $ 12,623 $ 9,469 Work in progress 3,061 1,312 Finished goods 2,597 3,562 Reserves (402 ) (614 ) Inventories, net $ 17,879 $ 13,729

Note C - Property and Equipme20

Note C - Property and Equipment (Tables)	6 Months Ended
	Dec. 31, 2017
Notes Tables
Property, Plant and Equipment [Table Text Block]	Depreciable Life In Years December 31 , 2017 June 30, 201 7 Land N/A $ 1,200 $ 1,200 Building and building improvements 7 – 39 3,715 3,706 Machinery and equipment 3 – 12 25,499 24,194 Office equipment and furniture 3 – 5 4,350 3,954 Vehicles 3 209 209 Leasehold improvements 1 – 15 17,032 17,038 Total property and equipment 52,005 50,301 Less: accumulated depreciation and amortization (33,272 ) (32,165 ) Property and equipment, net $ 18,733 $ 18,136

Note D - Other Comprehensive 21

Note D - Other Comprehensive (Loss) Income (Tables)	6 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Three Months Ended Six Months Ended December 31, 201 7 December 31, 201 7 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Be ginning Balance $ (491 ) $ (1,548 ) $ (2,039 ) $ (491 ) $ (414 ) $ (905 ) OCI/OCL before reclassifications - (490 ) (490 ) - (2,443 ) (2,443 ) Amounts reclassified from OCI - 187 187 - 365 365 Tax effect of OCI activity - 106 106 - 747 747 Net current period OCI/OCL - (197 ) (197 ) - (1,331 ) (1,331 ) Ending Balance $ (491 ) $ (1,745 ) $ (2,236 ) $ (491 ) $ (1,745 ) $ (2,236 ) Three Months Ended Six Months Ended December 31, 2016 December 31, 2016 Unrealized Unrealized Defined Gains Defined Gains Benefit (Losses) on Benefit (Losses) on Pension Cash Flow Pension Cash Flow Plan Hedges Total Plan Hedges Total Beginning Balance $ (775 ) $ (295 ) $ (1,070 ) $ (775 ) $ 95 $ (680 ) OCI/OCL before reclassifications - 2,287 2,287 - 1,834 1,834 Amounts reclassified from OCI - (343 ) (343 ) - (501 ) (501 ) Tax effect of OCI activity - (702 ) (702 ) - (481 ) (481 ) Net current period OCI/OCL - 1,242 1,242 - 852 852 Ending Balance $ (775 ) $ 947 $ 172 $ (775 ) $ 947 $ 172

Note F - Economic Dependency (T

Note F - Economic Dependency (Tables)	6 Months Ended
	Dec. 31, 2017
Supplier Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 201 7 2016 201 7 2016 Supplier 1 $ (a) (a) $ 2,992 (a) Supplier 2 1,684 (a) 2,911 (a) Supplier 3 1,718 (a) (a) (a) $ 3,402 — $ 5,903 —
Customer Concentration Risk [Member]
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 201 7 2016 201 7 2016 Customer 1 $ 19,134 $ 15,074 $ 32,292 $ 32,152 Customer 2 4,079 (a) 7,239 (a) $ 23,213 $ 15,074 $ 39,531 $ 32,152

Note G - Segment Information (T

Note G - Segment Information (Tables)	6 Months Ended
	Dec. 31, 2017
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2017 2016 2017 2016 Net Sales Private label contract manufacturing $ 29,355 $ 23,864 $ 51,577 $ 51,243 Patent and trademark licensing 3,980 6,695 9,832 13,383 Total Net Sales $ 33,335 $ 30,559 $ 61,409 $ 64,626 Three Months Ended December 31, Six Months Ended December 31, 2017 2016 2017 2016 Income from Operations Private label contract manufacturing $ 3,385 $ 2,148 $ 5,641 $ 5,462 Patent and trademark licensing 504 2,340 1,692 4,240 Income from operations of reportable segments 3,889 4,488 7,333 9,702 Corporate expenses not allocated to segments (1,608 ) (1,375 ) (3,169 ) (3,053 ) Total Income from Operations $ 2,281 $ 3,113 $ 4,164 $ 6,649
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Total Assets December 31, 201 7 June 30, 201 7 Private label contract manufacturing $ 72,115 $ 60,489 Patent and Trademark Licensing 12,472 12,122 Total $ 84,587 $ 72,611
Revenue from External Customers by Geographic Areas [Table Text Block]	Three Months Ended December 31, Six Months Ended December 31, 2017 2016 2017 2016 United States $ 16,426 $ 13,654 $ 31,620 $ 28,879 Markets outside of the United States 16,909 16,905 29,789 35,747 Total $ 33,335 $ 30,559 $ 61,409 $ 64,626
Long-lived Assets by Geographic Areas [Table Text Block]	Long-Lived Assets Total Assets Capital Expenditures Six Months Ended December 31, 201 7 June 30, 201 7 December 31, 201 7 June 30, 201 7 December 31, 201 7 December 31, 201 6 United States $ 10,461 $ 10,753 $ 53,353 $ 47,777 $ 426 $ 1,812 Europe 8,272 7,383 31,234 24,834 1,669 1,550 $ 18,733 $ 18,136 $ 84,587 $ 72,611 $ 2,095 $ 3,362

Note A - Basis of Presentatio24

Note A - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual)	Aug. 07, 2017shares	Dec. 31, 2017USD ($)shares	Dec. 31, 2016USD ($)shares	Dec. 31, 2017USD ($)shares	Dec. 31, 2016USD ($)shares	Jun. 30, 2017USD ($)	Sep. 30, 2017USD ($)
Sales Discounts, Noncash				$ 408,000
Royalty and Licensing Revenue		$ 4,000,000	$ 6,700,000	9,800,000	13,400,000
Royalty Expense		160,000	250,000	444,000	566,000
Notes, Loans and Financing Receivable, Net, Current		1,500,000		1,500,000
Investment Income, Interest		$ 304,000	$ 133,000	$ 554,000	$ 249,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate				0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares		0	0	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares		0	0	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares		0	0	5,000	0
Allocated Share-based Compensation Expense		$ 302,000	$ 256,000	$ 603,000	$ 506,000
Foreign Currency Contracts, Liability, Fair Value Disclosure		2,700,000		$ 2,700,000		$ 521,000
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration of Risk Number of Major Customers				3	3
Concentration Risk, Percentage				76.10%		65.60%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Beta Alanine Raw Material Sale Customers [Member]
Concentration Risk, Percentage				15.60%		21.30%
Fair Value, Inputs, Level 1 [Member]
Fair Value, Net Asset (Liability)		0		$ 0		$ 0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Net Asset (Liability)		0		0		$ 0
Juice Plus + [Member]
Agreement, Term	5 years
Kaged Muscle LLC [Member] | Notes Receivable [Member]
Notes, Loans and Financing Receivable, Net, Current							$ 1,500,000
Notes, Loans and Financing Receivable, Interest Rate, Stated Percentage							1500.00%
Investment Income, Interest		$ 58,000		$ 58,000
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares		135,000	0	0	0
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares		813,665	0	0	0
Restricted Stock [Member] | 2009 Omnibus Stock Incentive Plan [Member] | Employees [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares		0	0	0
Restricted Stock [Member] | 2009 Omnibus Stock Incentive Plan [Member] | Management [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares				10,000
Restricted Stock [Member] | Juice Plus + [Member]
Stock Issuance Agreement, Shares Agreed to Grant | shares	500,000
Sales Discounts, Noncash		$ 245,000		$ 408,000

Note A - Basis of Presentatio25

Note A - Basis of Presentation and Summary of Significant Accounting Policies - Calculation of Basic and Diluted Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Numerator
Net (loss) income	$ (1,318)	$ 2,466	$ 116	$ 4,956
Denominator
Basic weighted average common shares outstanding (in shares)	6,615,355	6,567,468	6,610,937	6,562,932
Dilutive effect of stock options (in shares)		116,000	226,000	102,000
Diluted weighted average common shares outstanding (in shares)	6,615,355	6,683,356	6,836,567	6,665,159
Basic net (loss) income per common share (in dollars per share)	$ (0.20)	$ 0.38	$ 0.02	$ 0.76
Diluted net (loss) income per common share (in dollars per share)	$ (0.20)	$ 0.37	$ 0.02	$ 0.74

Note B - Inventories, Net - Sum

Note B - Inventories, Net - Summary of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Jun. 30, 2017
Raw materials	$ 12,623	$ 9,469
Work in progress	3,061	1,312
Finished goods	2,597	3,562
Reserves	(402)	(614)
Inventories, net	$ 17,879	$ 13,729

Note C - Property and Equipme27

Note C - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2017	Jun. 30, 2017
Property and equipment, gross	$ 52,005	$ 50,301
Less: accumulated depreciation and amortization	(33,272)	(32,165)
Property and equipment, net	$ 18,733	18,136
Land [Member]
Depreciable Life In Years (Year)
Property and equipment, gross	$ 1,200	1,200
Building and Building Improvements [Member]
Property and equipment, gross	$ 3,715	3,706
Building and Building Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	7 years
Building and Building Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	39 years
Machinery and Equipment [Member]
Property and equipment, gross	$ 25,499	24,194
Machinery and Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Machinery and Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	12 years
Office Equipment [Member]
Property and equipment, gross	$ 4,350	3,954
Office Equipment [Member] | Minimum [Member]
Depreciable Life In Years (Year)	3 years
Office Equipment [Member] | Maximum [Member]
Depreciable Life In Years (Year)	5 years
Vehicles [Member]
Depreciable Life In Years (Year)	3 years
Property and equipment, gross	$ 209	209
Leasehold Improvements [Member]
Property and equipment, gross	$ 17,032	$ 17,038
Leasehold Improvements [Member] | Minimum [Member]
Depreciable Life In Years (Year)	1 year
Leasehold Improvements [Member] | Maximum [Member]
Depreciable Life In Years (Year)	15 years

Note D - Other Comprehensive Lo

Note D - Other Comprehensive Loss - Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Beginning Balance			$ (905)
Ending Balance	$ (2,236)		(2,236)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]
Beginning Balance	(491)	$ (775)	(491)	$ (775)
OCI/OCL before reclassifications
Amounts reclassified from OCI
Tax effect of OCI activity
Net current period OCI/OCL
Ending Balance	(491)	(775)	(491)	(775)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Beginning Balance	(1,548)	(295)	(414)	95
OCI/OCL before reclassifications	(490)	2,287	(2,443)	1,834
Amounts reclassified from OCI	187	(343)	365	(501)
Tax effect of OCI activity	106	(702)	747	(481)
Net current period OCI/OCL	(197)	1,242	(1,331)	852
Ending Balance	(1,745)	947	(1,745)	947
AOCI Attributable to Parent [Member]
Beginning Balance	(2,039)	(1,070)	(905)	(680)
OCI/OCL before reclassifications	(490)	2,287	(2,443)	1,834
Amounts reclassified from OCI	187	(343)	365	(501)
Tax effect of OCI activity	106	(702)	747	(481)
Net current period OCI/OCL	(197)	1,242	(1,331)	852
Ending Balance	$ (2,236)	$ 172	$ (2,236)	$ 172

Note E - Debt (Details Textual)

Note E - Debt (Details Textual) - USD ($)	6 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Sep. 29, 2017	Jun. 30, 2017
Notes, Loans and Financing Receivable, Net, Current	$ 1,500,000
Proceeds from Long-term Lines of Credit	0
Line of Credit Facility, Remaining Borrowing Capacity	10,000,000
Notes Receivable [Member] | Kaged Muscle LLC [Member]
Notes, Loans and Financing Receivable, Net, Current		$ 1,500,000
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member]
Line of Credit Facility, Maximum Borrowing Capacity	10,000,000
Line of Credit Facility, Maximum Lending Capacity Using Borrowed Funds			$ 1,500,000
Line of Credit Facility, Commitment Fee Amount	0
Long-term Line of Credit	0
Long-term Debt, Percentage Bearing Fluctuating Interest, Threshold Amount	100,000
Minimum Prepayment Amount Under Line of Credit	$ 100,000
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	1.25%
Debt Instrument Basis Spread on Elected Fixed Rate Borrowing	1.25%
Wells Fargo Bank, N.A. [Member] | Credit Agreement [Member] | Maximum [Member]
Ratio of Indebtedness to Net Capital	1.25
Ratio of Total Current Assets to Total Current Liabilities	1.75

Note F - Economic Dependency -

Note F - Economic Dependency - Substantial Net Sales to Certain Customers (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016		Dec. 31, 2017	Dec. 31, 2016
Net sales	$ 33,335	$ 30,559		$ 61,409	$ 64,626
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member]
Net sales	23,213	15,074		39,531	32,152
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Customer 1 [Member]
Net sales	19,134	15,074		32,292	32,152
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Customer 2 [Member]
Net sales	$ 4,079		[1]	$ 7,239		[1]
[1]	Sales were less than 10% of the respective period's total revenues.

Note F - Economic Dependency 31

Note F - Economic Dependency - Substantial Net Purchase From Certain Supplier (Details) - Supplier Concentration Risk [Member] - Raw Material Purchases [Member] - USD ($) $ in Thousands		3 Months Ended			6 Months Ended
		Dec. 31, 2017	Dec. 31, 2016		Dec. 31, 2017		Dec. 31, 2016
Raw Material Purchases by Supplier		$ 3,402			$ 5,903	[1]
Supplier 1 [Member]
Raw Material Purchases by Supplier	[1]				2,992
Supplier 2 [Member]
Raw Material Purchases by Supplier		1,684		[1]	2,911			[1]
Supplier 3 [Member]
Raw Material Purchases by Supplier		$ 1,718		[1]		[1]		[1]
[1]	Purchases were less than 10% of the respective period's total raw material purchases.

Note G - Segment Information (D

Note G - Segment Information (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Number of Reportable Segments			2
Revenue, Net	$ 33,335	$ 30,559	$ 61,409	$ 64,626
Non-US [Member]
Revenue, Net	16,909	16,905	29,789	35,747
UNITED STATES
Revenue, Net	$ 16,426	$ 13,654	$ 31,620	$ 28,879
Products Manufactured by NAIE [Member] | Non-US [Member] | Product Concentration Risk [Member]
Concentration Risk, Percentage	81.00%	60.00%	79.00%	53.00%
Products Manufactured by NAIE [Member] | UNITED STATES
Revenue, Net	$ 0	$ 0	$ 0	$ 0

Note G - Segment Information -

Note G - Segment Information - Operating Results by Business Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Net sales	$ 33,335	$ 30,559	$ 61,409	$ 64,626
Income from operations	2,281	3,113	4,164	6,649
Operating Segments [Member]
Income from operations	3,889	4,488	7,333	9,702
Corporate, Non-Segment [Member]
Income from operations	(1,608)	(1,375)	(3,169)	(3,053)
Private Label Contract Manufacturing [Member]
Net sales	29,355	23,864	51,577	51,243
Private Label Contract Manufacturing [Member] | Operating Segments [Member]
Income from operations	3,385	2,148	5,641	5,462
Patent and Trademark Licensing [Member]
Net sales	3,980	6,695	9,832	13,383
Patent and Trademark Licensing [Member] | Operating Segments [Member]
Income from operations	$ 504	$ 2,340	$ 1,692	$ 4,240

Note G - Segment Information 34

Note G - Segment Information - Assets by Business Segment (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Jun. 30, 2017
Total assets	$ 84,587	$ 72,611
Private Label Contract Manufacturing [Member]
Total assets	72,115	60,489
Patent and Trademark Licensing [Member]
Total assets	$ 12,472	$ 12,122

Note G - Segment Information 35

Note G - Segment Information - Net Sales by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Net sales	$ 33,335	$ 30,559	$ 61,409	$ 64,626
UNITED STATES
Net sales	16,426	13,654	31,620	28,879
Non-US [Member]
Net sales	$ 16,909	$ 16,905	$ 29,789	$ 35,747

Note G - Segment Information 36

Note G - Segment Information - Assets and Capital Expenditures by Geographical Region (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Jun. 30, 2017
Long-Lived Assets	$ 18,733		$ 18,136
Total assets	84,587		72,611
Capital Expenditures	2,095	$ 3,362
UNITED STATES
Long-Lived Assets	10,461		10,753
Total assets	53,353		47,777
Capital Expenditures	426	1,812
Europe [Member]
Long-Lived Assets	8,272		7,383
Total assets	31,234		$ 24,834
Capital Expenditures	$ 1,669	$ 1,550

Note H - Income Taxes (Details

Note H - Income Taxes (Details Textual) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Jun. 30, 2018
Effective Income Tax Rate Reconciliation, Percent	153.10%	29.60%	97.31%	30.10%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	28.06%		28.06%
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Transition Tax Liability	$ 1,815,966		$ 1,815,966
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount	775,000		775,000
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability	664,000		664,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 0		$ 0
Earliest Tax Year [Member] | Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Open Tax Year			2,014
Earliest Tax Year [Member] | Foreign Tax Authority [Member] | Swiss Federal Tax Administration (FTA) [Member]
Open Tax Year			2,015
Earliest Tax Year [Member] | State and Local Jurisdiction [Member]
Open Tax Year			2,007
Scenario, Forecast [Member]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent					28.06%

Note I - Treasury Stock (Detail

Note I - Treasury Stock (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Mar. 28, 2017	May 11, 2015	Feb. 06, 2015	Jun. 02, 2011
Stock Repurchase Program, Authorized Amount					$ 7,000,000	$ 5,000,000	$ 3,000,000	$ 2,000,000
Shares Paid for Tax Withholding for Share Based Compensation	7,264	367	7,998	6,404
Shares Paid for Tax Withholding for Share-based Compensation, Average Cost Per Share	$ 10.80	$ 12.30	$ 10.79	$ 13.09
Payments Related to Tax Withholding for Share-based Compensation	$ 78,000	$ 5,000	$ 86,000	$ 84,000
Excluding Restricted Stock Purchased [Member]
Treasury Stock, Shares, Acquired	0	0	0	0
2015 Increase [Member]
Stock Repurchase Program, Authorized Amount						$ 2,000,000	$ 1,000,000
2017 Increase [Member]
Stock Repurchase Program, Authorized Amount					$ 2,000,000

Note J - Derivatives and Hedg39

Note J - Derivatives and Hedging (Details Textual) € in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2017EUR (€)	Jun. 30, 2017USD ($)
Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net	$ 0	$ 92,000	$ 0	$ 92,000
Unrealized Loss on Foreign Currency Derivatives, before Tax			2,700,000
Cash Flow Hedge Derivative Instrument Liabilities at Fair Value	2,700,000		2,700,000
Hedging Liabilities, Current	2,088,000		2,088,000			$ 422,000
Hedging Liabilities, Noncurrent	609,000		609,000			$ 99,000
Derivative Instruments, Loss Recognized in Other Comprehensive Income (Loss), Effective Portion	731,000
Reclassification out of Accumulated Other Comprehensive Income [Member]
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	2,000,000		2,000,000
Cash Flow Hedging [Member]
Derivative Instruments, Loss Recognized in Other Comprehensive Income (Loss), Effective Portion			2,900,000
Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion	428,000		850,000
Derivative Instruments, Gain Recognized in Other Comprehensive Income (Loss), Effective Portion		2,300,000		1,800,000
Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion		$ 213,000		$ 271,000
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member]
Derivative, Notional Amount	$ 52,600,000		$ 52,600,000		€ 45.3